A detailed history of Financial Perspectives, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Perspectives, Inc holds 11,360 shares of NVO stock, worth $1.62 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
11,360
Previous 11,345 0.13%
Holding current value
$1.62 Million
Previous $1.17 Billion 24.28%
% of portfolio
0.55%
Previous 0.48%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$102.11 - $135.92 $1,531 - $2,038
15 Added 0.13%
11,360 $1.46 Billion
Q4 2023

Feb 01, 2024

BUY
$87.78 - $105.45 $2,984 - $3,585
34 Added 0.3%
11,345 $1.17 Billion
Q3 2023

Jan 09, 2024

BUY
$90.94 - $199.54 $514,356 - $1.13 Million
5,656 Added 100.02%
11,311 $1.03 Billion
Q4 2022

Jan 09, 2024

BUY
$102.55 - $135.33 $3,794 - $5,007
37 Added 0.66%
5,655 $765 Million
Q1 2022

Jan 09, 2024

BUY
$93.1 - $112.54 $21,413 - $25,884
230 Added 4.27%
5,618 $624 Million
Q4 2021

Jan 09, 2024

BUY
$95.88 - $117.08 $138,930 - $169,648
1,449 Added 36.79%
5,388 $603 Million
Q3 2021

Jan 09, 2024

SELL
$84.42 - $106.62 $380,396 - $480,429
-4,506 Reduced 53.36%
3,939 $378 Million
Q2 2021

Jan 09, 2024

SELL
$67.66 - $84.76 $38 Million - $47.5 Million
-560,934 Reduced 98.52%
8,445 $707 Million
Q1 2021

Jan 09, 2024

BUY
$67.06 - $75.82 $37.6 Million - $42.5 Million
560,934 Added 6642.2%
569,379 $8.45 Million
Q4 2020

Jan 09, 2024

SELL
$63.89 - $73.8 $3,194 - $3,690
-50 Reduced 0.59%
8,445 $590 Million
Q3 2020

Jan 09, 2024

BUY
$63.69 - $70.22 $63 - $70
1 Added 0.01%
8,495 $590 Million
Q2 2020

Jan 09, 2024

BUY
$58.54 - $67.94 $117 - $135
2 Added 0.02%
8,494 $556 Million
Q4 2019

Jan 09, 2024

BUY
$49.86 - $58.26 $423,411 - $494,743
8,492 New
8,492 $492 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Financial Perspectives, Inc Portfolio

Follow Financial Perspectives, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.